New anticancer drugs under clinical trials in Japan

Hematol Oncol Clin North Am. 1994 Apr;8(2):277-87.

Abstract

A total of 16 drugs developed in Japan are currently under Phase I or II trials. This article reviews results of some studies of these drugs. Studies included in the article are of SM-5887, MX-2, DWA2114R, and CPT-11.

Publication types

  • Review

MeSH terms

  • Animals
  • Antibiotics, Antineoplastic / therapeutic use
  • Antineoplastic Agents / therapeutic use*
  • Carboplatin / analogs & derivatives
  • Carboplatin / therapeutic use
  • Cisplatin / analogs & derivatives
  • Clinical Trials, Phase I as Topic
  • Clinical Trials, Phase II as Topic
  • Humans
  • Japan
  • Organoplatinum Compounds / therapeutic use

Substances

  • Antibiotics, Antineoplastic
  • Antineoplastic Agents
  • Organoplatinum Compounds
  • DWA 2114
  • nedaplatin
  • Carboplatin
  • Cisplatin